7 results match your criteria: "University of British Columbia Southern Medical Program[Affiliation]"
Neurology
January 2025
From the Department of Clinical Neurosciences (M.W.K., J.R.S.), University of Calgary, Alberta; Division of Neurology (L.V.K.), Department of Medicine, Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Ontario; Department of Medicine (D.W.), University of British Columbia Southern Medical Program, Kelowna; Division of Neurology (T.A.M., M.G.S.), Department of Medicine, University of Ottawa, The Ottawa Hospital Ottawa, Ontario, Canada; Department of Neurology (J.M.), Rijnstate Hospital, Arnhem; Department of Neurology (E.M.M.S., B.U.), MS Center Amsterdam, Amsterdam University Medical Centers, the Netherlands; Section on Statistical Planning and Analysis (A.S.), Department of Neurology, UT Southwestern Medical Center, Dallas; and Department of Biostatistics (G.R.C.), University of Alabama at Birmingham.
Background And Objectives: Disease-modifying treatments (DMTs) are a major unmet need in Parkinson disease (PD). To date, trials investigating DMT candidates in PD most often used a randomized controlled trial (RCT) design. Unfortunately, RCTs to date have not led to a breakthrough, in part because of the large sample sizes and length of follow-up required.
View Article and Find Full Text PDFCan J Surg
September 2024
From the Department of Surgical Oncology, BC Cancer-Sindi Ahluwalia Hawkins Centre, Kelowna, B.C. (Downey, Baliski); the Cancer Surveillance and Outcomes, BC Cancer, Vancouver, B.C. (DeVries); the Department of Pathology, Kelowna General Hospital, Kelowna, B.C. (Lano); the University of British Columbia Southern Medical Program, Kelowna, B.C. (Baliski)
Background: The status of the regional lymph node basin is of prognostic importance in patients with melanoma, making the performance of sentinel lymph node biopsies (SLNBs) a key component of patient care management, particularly with the advent of immunotherapy for adjuvant treatment. The primary goal of our study was to assess the false-negative rate of SLNBs among patients with melanoma.
Methods: We conducted a retrospective review of patients with melanoma undergoing SLNB by a single surgeon between Jan.
Post Reprod Health
December 2024
Department of Medicine, University of British Columbia Southern Medical Program, Kelowna, BC, Canada.
Urinary incontinence is a prevalent condition affecting women. Pelvic floor physiotherapy is a specialized field of physiotherapy dedicated to assessing and treating pelvic floor muscles. This therapy has demonstrated benefits in addressing stress urinary incontinence in premenopausal women, with numerous studies supporting its efficacy in this population.
View Article and Find Full Text PDFAmyotroph Lateral Scler Frontotemporal Degener
May 2022
Montreal Neurological Institute-Hospital, McGill University, Montreal, Canada.
Am J Surg
May 2020
BC Cancer-Sindi Ahluwalia Hawkins Centre, Dept. of Surgical Oncology, 399 Royal Ave, Kelowna, BC, V1Y 5L3, Canada. Electronic address:
Background: Among melanoma patients with a tumor-positive sentinel node biopsy (SNB), approximately 20% harbor disease in non-sentinel nodes (nSN), as determined by a completion lymph node dissection (CLND). CLND lacks a survival benefit and has high morbidity. This study assesses predictive factors for nSN metastasis and validates five models predicting nSN metastasis.
View Article and Find Full Text PDFObjective: This study was conducted to analyse data from emergency ophthalmology referrals after-hours from different hospitals to identify the most common pathologies and compare accuracy of diagnoses. The primary objective was to identify common presenting entities and common causes of misdiagnosis in the emergency department to help guide education initiatives.
Design: This was a retrospective chart review that looked at consults occurring between September 1, 2015, and October 21, 2016.
Transfus Med
December 2010
Department of Medicine, Kelowna General Hospital, University of British Columbia Southern Medical Program, Kelowna, British Columbia, Canada.
Rationale: Intravenous immune globulin (IVIG) is a pooled human blood product. Much of IVIG use in Canada is prescribed for 'unlabelled' or 'off-label' indications. Due to costs, risk of use and limited supply, knowledge about the use of IVIG is important.
View Article and Find Full Text PDF